In this project the investigators study the safety and efficacy of the pipeline embolization device with vantage technology in treatment of unruptured brain aneurysms
Study Type
OBSERVATIONAL
Enrollment
50
Flow-diverter device occludes aneurysms through endoluminal reconstruction and remodelling of the parent artery.
Kings College Hospital
London, United Kingdom
Evaluate 30-day morbidity rates
We will evaluate short term clinical outcome in the form of morbidity rates 30 days after the procedure
Time frame: Done at 30 days post procedural
Evaluate 30-day mortality rates
We will evaluate short term clinical outcome in the form of mortality rates 30 days after the procedure
Time frame: Done at 30 days post procedural
Evaluate 1-year morbidity rates
We will evaluate long term clinical outcome in the form of morbidity rates \>30days up to 1 year after the procedure
Time frame: Done at >30days up to 1 year post procedural
Evaluate 1-year mortality rates
We will evaluate long term clinical outcome in the form of mortality rates \>30days up to 1 year after the procedure
Time frame: Done at >30days up to 1 year post procedural
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.